Sutro Biopharma (STRO) Receivables (2017 - 2026)
Sutro Biopharma's Receivables was $5.8 million in Q2 2026, down 27.5% from $8 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Sutro Biopharma came in at $3.98 million, down 53.8% from FY2024.
- Receivables shows a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
- In earlier years, Receivables was $8.62 million in FY2024 (-76.1%), $36.08 million in FY2023 (+406.6%), $7.12 million in FY2022 (-42.8%) and $12.45 million in FY2021 (+124.0%).
- Quarterly Receivables has moved between $3.92 million (Q3 2025) and $97.67 million (Q2 2022) over five years.
- Compared with a year earlier, Receivables was higher in 1 of the last seven quarters, with an average decline of 42.9%.
- The best year-over-year quarter for Receivables over five years was Q2 2022 (growth of 966.3%); the worst was Q2 2023 (a decline of 89.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | 5.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.80 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 13.56 Mn |
| Dec 31, 2024 | 8.62 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.95 Mn |
| Mar 31, 2024 | 31.30 Mn |
| Dec 31, 2023 | 36.08 Mn |
| Sep 30, 2023 | 16.63 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 9.87 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 11.24 Mn |
| Jun 30, 2022 | 97.67 Mn |
| Mar 31, 2022 | 11.69 Mn |
| Dec 31, 2021 | 12.45 Mn |
| Sep 30, 2021 | 12.33 Mn |
| Jun 30, 2021 | 9.16 Mn |
API Access
Sutro Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();